| 000 | 00000nam 2200000za 4500 |
| 001 | 9.815708 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107142058 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 180223s2017 onca ob f000 0 eng d |
|---|
| 020 | |a978-0-660-05248-9 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aFR5-38/4-2016E-PDF |
|---|
| 245 | 00|aInvest in Canada - Canada’s competitive advantages |h[electronic resource] : |bbiopharmaceuticals. |
|---|
| 246 | 30|aBiopharmaceuticals |
|---|
| 260 | |aOttawa : |bGlobal Affairs Canada, |c2017. |
|---|
| 300 | |a[6] p. : |bcol. ill. |
|---|
| 500 | |aIssued also in French under title: Investir au Canada - avantages concurrentiels du Canada : le secteur biopharmaceutique. |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"Spring 2017." |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 692 | 07|2gccst|aPharmaceutical industry |
|---|
| 692 | 07|2gccst|aForeign investments |
|---|
| 710 | 1 |aCanada. |bGlobal Affairs Canada. |
|---|
| 775 | 08|tInvestir au Canada - avantages concurrentiels du Canada |w(CaOODSP)9.815709 |
|---|
| 856 | 40|qPDF|s1.82 MB|uhttps://publications.gc.ca/collections/collection_2018/amc-gac/FR5-38-4-2016-eng.pdf |
|---|